Ziopharm Oncology reported $53.8M in Current Assets for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Amgen AMGN:US USD 22.19B 1.88B
AstraZeneca AZN:LN USD 22.59B 2.37B
Baxter International BAX:US USD 8.01B 201M
Biogen BIIB:US USD 9.79B 25.4M
Bioline Rx BLRX:US USD 57.94M 13.84M
Corcept Therapeutics CORT:US USD 499.25M 46.85M
Curis CRIS:US USD 92.12M 13.6M
Gilead Sciences GILD:US USD 15.23B 1.67B
GlaxoSmithKline GSK:LN GBP 20.77B 520M
Immunogen IMGN:US USD 304.12M 26.3M
Intercept Pharmaceuticals ICPT:US USD 540.13M 5.24M
Intrexon XON:US USD 118.16M 44.65M
Karyopharm Therapeutics KPTI:US USD 356.48M 133.8M
Novartis NOVN:VX USD 36.91B 44M
Ptc Therapeutics PTCT:US USD 693.78M 176.52M
Regeneron Pharmaceuticals REGN:US USD 22.06B 6.64B
Roche Holding ROG:VX 33.82B 3.5B
Sangamo Biosciences SGMO:US USD 300.33M 36.29M
Tg Therapeutics TGTX:US USD 168.27M 14.65M
Verastem VSTM:US USD 92.87M 15.89M
YTE INCY:US USD 4.09B 271.74M
Ziopharm Oncology ZIOP:US USD 53.8M 1.71M